MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05107nam a2200757Mi 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1311353619 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240726104516.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220419s2022 sz 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
3030900649 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030900649 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
GBVCP |
| Language of cataloging |
ger |
| Description conventions |
rda |
| Transcribing agency |
GBVCP |
| Modifying agency |
SBI |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
SBIM |
| 050 04 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA644 |
| Item number |
.C373 2022 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mallick, Umair |
| Relationship |
aut |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Cardiovascular complications of COVID-19 |
| Remainder of title |
risk, pathogenesis and outcomes |
| Statement of responsibility, etc. |
Umair Mallick. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cham, Switzerland |
| Name of publisher, distributor, etc. |
Springer |
| Date of publication, distribution, etc. |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 414 pages ; |
| Other physical details |
Illustrations. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographies and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Epidemiology of CoViD19 and Cardiovascular Diseases |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology -- |
| Title |
Discussion |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Virology of CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Viral Characteristics -- |
| Title |
Mechanism of Viral Entry in Cells |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
An Introduction to the Clinical and Diagnostic Features, and CoViD19 Complications |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Clinical Symptomatology -- |
| Title |
Sepsis and Complications of CoViD19 -- |
| -- |
Important Diagnostic Features |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Pathological Features of CoViD19 Cardiovascular Complications |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Key Features of Cardiovascular Pathology |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Treatment Options in CoViDI9 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Antiviral Agents in CoViD19 -- |
| Title |
Amino Quinolones in CoViD19 -- |
| -- |
Immune-Based Therapies in CoViD19 -- |
| -- |
Potential Anti-inflammatory Mechanisms -- |
| -- |
Anticoagulants -- |
| -- |
CoViD19 Vaccines |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Acute Pulmonary Injury -- |
| Title |
Sepsis and Multi-organ Failure -- |
| -- |
Renin Angiotensin System -- |
| -- |
Endothelin System -- |
| -- |
Immune-Inflammation |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Overview of Cytokines and CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cytokines -- |
| Title |
Cytokine Storm in CoViD19 -- |
| -- |
Cytokines in Cardiovascular and Metabolic Diseases |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Renin-Angiotensin System in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Renin Angiotensin System -- |
| Title |
The Dynamics of ACE2 Expression in CoViD19 -- |
| -- |
ACE2 is a Marker of Severity or a Compensatory Mechanism? |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Thrombosis in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Mechanisms Promoting Thrombosis in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Pathogenesis of CoViD19- Miscellaneous Mechanisms |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Regulatory Peptide Systems in CoViD19 -- |
| Title |
Miscellaneous Mechanisms |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Myocardial Injury in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology of Myocardial Injury -- |
| Title |
Definition, Presentation, and Challenges of Myocardial Injury -- |
| -- |
Timing and Assessment of Myocardial Injury -- |
| -- |
Biomarkers of Myocardial Injury -- |
| -- |
Pathogenesis of the Myocardial Injury |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Heart Failure in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology -- |
| Title |
Role of Comorbidities in Heart Failure with CoViD19 -- |
| -- |
Biomarkers of Heart Failure in CoViD19 -- |
| -- |
Pathogenetic Mechanisms of Heart Failure in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Hypertension in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology -- |
| Title |
Complexities in Hypertension and CoViD19 -- |
| -- |
CoViD19 Susceptibility and Hypertension -- |
| -- |
Pathogenesis |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cardiac Arrhythmias in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology of Arrhythmias in CoViD19 -- |
| Title |
Pathogenesis of Arrhythmias in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Acute Coronary Syndromes in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology of Acute Coronary Syndromes in CoViD19 -- |
| Title |
Defining Acute Coronary Syndromes, Challenges in Presentation and Assessment -- |
| -- |
Pathogenesis of Acute Coronary Syndromes in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Diabetes Mellitus and COVID19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology -- |
| Title |
Pathogenesis -- |
| -- |
Treatment Implications |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Obesity and COVID19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Pathogenetic Links - Obesity and CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Older Age Adults and CoViD19 -- |
| Title |
Epidemiology |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Gender Disparity in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology -- |
| Title |
Discrepancies in the Epidemiological Data -- |
| -- |
Factors Associated with Gender Dichotomy -- |
| -- |
Gender Disparity in Immune Response -- |
| -- |
Gender Disparity in ACE2 Mechanisms -- |
| -- |
Gender Disparity in Cardiovascular Diseases |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
An Overview of Quality of Research in CoViD19 |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Quality Issues in CoViD19 Research and Improvement Initiatives. |
| 520 0# - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19." |
| Assigning source |
|
| 530 ## - COPYRIGHT INFORMATION: |
|---|
| COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
| Uniform Resource Identifier |
<a href="b">b</a> |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
MEDICAL. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Nursing-Reference (LIBRARY USE ONLY) |
| VENDOR |
AMAZON |
| Classification part |
RA |
| Delivery Date: ACADEMIC YEAR - ie 2022-2023 |
2021-2022 |
| COST |
159.99 |
| PUBLICATION YEAR |
2022 |
| print -BUDGET LINE 10-1411-7022-? |
NURS |
| INVOICE NUMBER: |
112-3371828-6508253 |
| REQUESTED BY: |
NURSING DEPARTMENT |
| Source of classification or shelving scheme |
Library of Congress Classification |
| REPLACEMENT COST (GET FROM AMAZON) |
159.99 |
| 902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
|---|
| a |
1 |
| b |
Cynthia Snell |
| c |
1 |
| d |
Cynthia Snell |